OneSource Specialty Pharma Limited (BOM:544292)

Market Cap	204.98B
Revenue (ttm)	14.80B
Net Income (ttm)	-126.10M
Shares Out	n/a
EPS (ttm)	-1.19
PE Ratio	n/a
Forward PE	43.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,276
Average Volume	5,423
Open	1,721.50
Previous Close	1,759.60
Day's Range	1,680.25 - 1,796.20
52-Week Range	1,163.05 - 2,249.65
Beta	n/a
RSI	40.23
Earnings Date	Nov 4, 2025

About BOM:544292

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pe...

• Industry: Commercial Physical and Biological Research
• Founded: 2007
• Employees: 1,412
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544292

Financial Performance

In 2024, BOM:544292's revenue was 14.45 billion, an increase of 740.43% compared to the previous year's 1.72 billion. Losses were -179.71 million, -95.41% less than in 2023.